Bidders for health marketing firm Klick Health "did a lot of work" around the Trump admin's threat to ban pharma advertising, sources familiar with the situation tells Axios.
Why it matters: The deal got struck at an 18x EBITDA multiple despite the regulatory uncertainty.
